353 related articles for article (PubMed ID: 9543391)
1. Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases.
Kubota Y; Angelotti T; Niederfellner G; Herbst R; Ullrich A
Cell Growth Differ; 1998 Mar; 9(3):247-56. PubMed ID: 9543391
[TBL] [Abstract][Full Text] [Related]
2. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
4. Uncoupling of the proliferation and differentiation signals mediated by the murine macrophage colony-stimulating factor receptor expressed in myeloid FDC-P1 cells.
Bourette RP; Myles GM; Carlberg K; Chen AR; Rohrschneider LR
Cell Growth Differ; 1995 Jun; 6(6):631-45. PubMed ID: 7545432
[TBL] [Abstract][Full Text] [Related]
5. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
6. Responses of the murine myeloid cell line FDC-P1 to soluble and membrane-bound forms of steel factor (SLF).
Caruana G; Ashman LK; Fujita J; Gonda TJ
Exp Hematol; 1993 Jun; 21(6):761-8. PubMed ID: 7684700
[TBL] [Abstract][Full Text] [Related]
7. Fms-like tyrosine kinase 3 catalytic domain can transduce a proliferative signal in FDC-P1 cells that is qualitatively similar to the signal delivered by c-Fms.
Rossner MT; McArthur GA; Allen JD; Metcalf D
Cell Growth Differ; 1994 May; 5(5):549-55. PubMed ID: 8049161
[TBL] [Abstract][Full Text] [Related]
8. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
Ram TG; Hosick HL; Ethier SP
J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304
[TBL] [Abstract][Full Text] [Related]
9. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
10. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
Qi JH; Claesson-Welsh L
Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
Shivakrupa R; Bernstein A; Watring N; Linnekin D
Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the mitogenic pathway of the FLT3 receptor and characterization in its C terminal region of a specific binding site for the PI3' kinase.
Casteran N; Rottapel R; Beslu N; Lecocq E; Birnbaum D; Dubreuil P
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):443-56. PubMed ID: 7920189
[TBL] [Abstract][Full Text] [Related]
13. The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner.
Ekman N; Arighi E; Rajantie I; Saharinen P; Ristimäki A; Silvennoinen O; Alitalo K
Oncogene; 2000 Aug; 19(36):4151-8. PubMed ID: 10962576
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
Wu CJ; Chen Z; Ullrich A; Greene MI; O'Rourke DM
Oncogene; 2000 Aug; 19(35):3999-4010. PubMed ID: 10962556
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of pp60c-src kinase activity in FDC-P1 cells by polyoma middle-T antigen and hematopoietic growth factors.
Muser J; Kaech S; Moroni C; Ballmer-Hofer K
Oncogene; 1989 Dec; 4(12):1433-9. PubMed ID: 2480561
[TBL] [Abstract][Full Text] [Related]
16. Epitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, YB5.B8, 17F11, and SR-1.
Ashman LK; Bühring HJ; Aylett GW; Broudy VC; Müller C
J Cell Physiol; 1994 Mar; 158(3):545-54. PubMed ID: 7510297
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic growth factor receptors.
Brizzi MF; Avanzi GC; Pegoraro L
Int J Cell Cloning; 1991 Jul; 9(4):274-300. PubMed ID: 1894957
[TBL] [Abstract][Full Text] [Related]
18. The cytokine receptor repertoire specifies autocrine growth factor production in factor-dependent cells.
Rasko JE; Metcalf D; Gough NM; Begley CG
Exp Hematol; 1995 May; 23(5):453-60. PubMed ID: 7720817
[TBL] [Abstract][Full Text] [Related]
19. Growth, differentiation and survival of HC11 mammary epithelial cells: diverse effects of receptor tyrosine kinase-activating peptide growth factors.
Merlo GR; Graus-Porta D; Cella N; Marte BM; Taverna D; Hynes NE
Eur J Cell Biol; 1996 Jun; 70(2):97-105. PubMed ID: 8793381
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.
Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Druker BJ; Lydon NB
Cancer Res; 1996 Jan; 56(1):100-4. PubMed ID: 8548747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
